NSRGY - InMode Files Proposed Terms For U.S. IPO
Quick Take
InMode (INMD) has filed to raise gross proceeds of $75 million from a U.S. IPO, according to an F-1/A registration statement.
The firm provides minimally-invasive surgical aesthetic and medical treatment solutions for physicians.
INMD is growing smartly, is profitable and cash flow positive, and the IPO is reasonably priced at $15.00 per share.
Company & Technology
Yokneam, Israel-based InMode was founded in 2008 to provide minimally-invasive face and body contouring, medical aesthetics and women’s health products and solutions.
Management is headed by Co-Founder and CEO Moshe Mizrahy, who previously co-founded